NAV
$43.81
AUM
$810.7M
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.02
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +25.46% | +11.99% | +22.74% | +35.44% | +20.29% | +9.97% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | 000660.KS | SK Hynix Inc | 11.98% |
| 2 | ASML.AS | ASML Holding NV | 6.14% |
| 3 | NOVN.SW | Novartis AG Registered Shares | 3.80% |
| 4 | ROP.SW | Roche Holding AG Ordinary Shares new | 3.74% |
| 5 | 6857.T | Advantest Corp | 3.18% |
| 6 | RR.L | Rolls-Royce Holdings PLC | 2.79% |
| 7 | ABBN.SW | ABB Ltd | 2.53% |
| 8 | SAF.PA | Safran SA | 2.44% |
| 9 | ALV.DE | Allianz SE | 2.38% |
| 10 | 8035.T | Tokyo Electron Ltd | 2.27% |
The fund will invest at least 90% of its total assets in securities that comprise the underlying index. The index provider compiles, maintains and calculates the underlying index, which is composed of constituents of the S&P Developed ex-U.S. LargeMidCap Index that the index provider identifies as being of the highest quality-that is, stocks of companies that seek to generate higher revenue and cash flow than their counterparts through prudent use of assets and finances.
Inception Date: 2007-06-13